[HTML][HTML] Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease
Alzheimer's disease (AD) is a neurodegenerative disorder that causes progressive loss of
cognitive functions like thinking, memory, reasoning, behavioral abilities, and social skills …
cognitive functions like thinking, memory, reasoning, behavioral abilities, and social skills …
Multifaceted Alzheimer's disease: Building a roadmap for advancement of novel therapies
D Kaur, T Behl, A Sehgal, S Singh, N Sharma… - Neurochemical …, 2021 - Springer
Alzheimer's disease (AD) is one of the most prevailing neurodegenerative disorders of
elderly humans associated with cognitive damage. Biochemical, epigenetic, and …
elderly humans associated with cognitive damage. Biochemical, epigenetic, and …
[HTML][HTML] Perspective insights into disease progression, diagnostics, and therapeutic approaches in Alzheimer's disease: a judicious update
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive
accumulation of β-amyloid fibrils and abnormal tau proteins in and outside of neurons …
accumulation of β-amyloid fibrils and abnormal tau proteins in and outside of neurons …
[图书][B] Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease
Alzheimer's disease (AD) is still a hardly curable disease with several symptoms of
behavioral and cognitive impairments. Besides the altered protein levels and the side effects …
behavioral and cognitive impairments. Besides the altered protein levels and the side effects …
[HTML][HTML] Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the Alzheimer's brain?
G Moya-Alvarado, N Gershoni-Emek, E Perlson… - Molecular & Cellular …, 2016 - ASBMB
Neurodegenerative diseases, such as Alzheimer′ s diseases (AD), are becoming more
prevalent as the population ages. However, the mechanisms that lead to synapse …
prevalent as the population ages. However, the mechanisms that lead to synapse …
[HTML][HTML] Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and Treatments
KL Nystuen, SM McNamee, M Akula, KM Holton… - Bioengineering, 2024 - mdpi.com
Alzheimer's Disease (AD) is a complex neurodegenerative disease resulting in progressive
loss of memory, language and motor abilities caused by cortical and hippocampal …
loss of memory, language and motor abilities caused by cortical and hippocampal …
The involvement of post-translational modifications in Alzheimer's disease
S Marcelli, M Corbo, F Iannuzzi, L Negri… - Current Alzheimer …, 2018 - ingentaconnect.com
Background: Alzheimer's disease (AD) is a neurodegenerative disorder recognized as the
most common cause of chronic dementia among the ageing population. AD is …
most common cause of chronic dementia among the ageing population. AD is …
[HTML][HTML] Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease
K Rajasekhar, T Govindaraju - RSC advances, 2018 - pubs.rsc.org
Alzheimer's disease (AD) is the most prevalent, progressive and multifaceted
neurodegenerative disorder associated with cognition, memory and behavioural …
neurodegenerative disorder associated with cognition, memory and behavioural …
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease
M Kashif, P Sivaprakasam, P Vijendra… - Current …, 2023 - ingentaconnect.com
Aim: Alzheimer's disease (AD) has been identified as a progressive brain disorder
associated with memory dysfunction and the accumulation of β-amyloid plaques and …
associated with memory dysfunction and the accumulation of β-amyloid plaques and …
Recent update on the Alzheimer's disease progression, diagnosis and treatment approaches
Alzheimer's disease (AD) is a multifactorial, progressive, neurodegenerative disorder,
manifested by the loss of memory and cognitive abilities, behavioral disturbance and …
manifested by the loss of memory and cognitive abilities, behavioral disturbance and …